Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)

Germline/somatic BRCA-mutated ovarian carcinomas (OC) are associated to have better response with platinum-based chemotherapy and long-term prognosis than non-BRCA-associated OCs. In addition, these mutations are predictive factors to response to Poly(ADP-ribose) polymerase (PARP) inhibitors. Differ...

Descripción completa

Detalles Bibliográficos
Autores: Palacios, José, de la Hoya, M., Bellosillo, B., de Juan, I., Matias-Guiu, Xavier, Lázaro, Conxi, Palanca, S., Osorio, A., Rojo, Federico, Rosa-Rosa, Juan Manuel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Universitat de Lleida (UdL)
Repositorio:Repositori Obert UdL
OAI Identifier:oai:repositori.udl.cat:10459.1/467695
Acceso en línea:https://doi.org/10.1007/s00428-019-02709-3
https://hdl.handle.net/10459.1/467695
Access Level:acceso abierto
Palabra clave:BRCA
Next-generation sequencing (NGS)
Ovarian cancer (OC)
id ES_3d16d0a569ee8a8bd83cc64a9b4b6af3
oai_identifier_str oai:repositori.udl.cat:10459.1/467695
network_acronym_str ES
network_name_str España
repository_id_str
spelling Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)Palacios, Joséde la Hoya, M.Bellosillo, B.de Juan, I.Matias-Guiu, XavierLázaro, ConxiPalanca, S.Osorio, A.Rojo, FedericoRosa-Rosa, Juan ManuelBRCANext-generation sequencing (NGS)Ovarian cancer (OC)Germline/somatic BRCA-mutated ovarian carcinomas (OC) are associated to have better response with platinum-based chemotherapy and long-term prognosis than non-BRCA-associated OCs. In addition, these mutations are predictive factors to response to Poly(ADP-ribose) polymerase (PARP) inhibitors. Different positioning papers have addressed the clinical recommendations for BRCA testing in OC. This consensus guide represents a collection of technical recommendations to address the detection of BRCA1/2 mutations in the molecular diagnostic testing strategy for OC. Under the coordination of Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH), these recommendations have been developed by pathologists and geneticists taking into account previously published recommendations and their experience in the molecular characterization of these genes. Since the implementation of BRCA testing as a predictive factor can initiate the workflow by testing germline mutations in the blood or by testing both germline and somatic mutations in tumor tissue, distinctive features of both strategies are discussed. Additionally, the recommendations included in this paper provide some references, quality parameters, and genomic tools aimed to standardize and facilitate the clinical genomic diagnosis of OC.Springer Nature2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://doi.org/10.1007/s00428-019-02709-3https://hdl.handle.net/10459.1/467695reponame:Repositori Obert UdL instname:Universitat de Lleida (UdL)InglésReproducció del document publicat a: https://doi.org/10.1007/s00428-019-02709-3Virchows Archiv, 2020, vol. 476, p. 195-207cc-by (c)The authors, 2019Attribution 4.0 Internationalinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/oai:repositori.udl.cat:10459.1/4676952026-06-24T12:42:17Z
dc.title.none.fl_str_mv Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
title Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
spellingShingle Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
Palacios, José
BRCA
Next-generation sequencing (NGS)
Ovarian cancer (OC)
title_short Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
title_full Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
title_fullStr Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
title_full_unstemmed Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
title_sort Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
dc.creator.none.fl_str_mv Palacios, José
de la Hoya, M.
Bellosillo, B.
de Juan, I.
Matias-Guiu, Xavier
Lázaro, Conxi
Palanca, S.
Osorio, A.
Rojo, Federico
Rosa-Rosa, Juan Manuel
author Palacios, José
author_facet Palacios, José
de la Hoya, M.
Bellosillo, B.
de Juan, I.
Matias-Guiu, Xavier
Lázaro, Conxi
Palanca, S.
Osorio, A.
Rojo, Federico
Rosa-Rosa, Juan Manuel
author_role author
author2 de la Hoya, M.
Bellosillo, B.
de Juan, I.
Matias-Guiu, Xavier
Lázaro, Conxi
Palanca, S.
Osorio, A.
Rojo, Federico
Rosa-Rosa, Juan Manuel
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv BRCA
Next-generation sequencing (NGS)
Ovarian cancer (OC)
topic BRCA
Next-generation sequencing (NGS)
Ovarian cancer (OC)
description Germline/somatic BRCA-mutated ovarian carcinomas (OC) are associated to have better response with platinum-based chemotherapy and long-term prognosis than non-BRCA-associated OCs. In addition, these mutations are predictive factors to response to Poly(ADP-ribose) polymerase (PARP) inhibitors. Different positioning papers have addressed the clinical recommendations for BRCA testing in OC. This consensus guide represents a collection of technical recommendations to address the detection of BRCA1/2 mutations in the molecular diagnostic testing strategy for OC. Under the coordination of Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH), these recommendations have been developed by pathologists and geneticists taking into account previously published recommendations and their experience in the molecular characterization of these genes. Since the implementation of BRCA testing as a predictive factor can initiate the workflow by testing germline mutations in the blood or by testing both germline and somatic mutations in tumor tissue, distinctive features of both strategies are discussed. Additionally, the recommendations included in this paper provide some references, quality parameters, and genomic tools aimed to standardize and facilitate the clinical genomic diagnosis of OC.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.1007/s00428-019-02709-3
https://hdl.handle.net/10459.1/467695
url https://doi.org/10.1007/s00428-019-02709-3
https://hdl.handle.net/10459.1/467695
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1007/s00428-019-02709-3
Virchows Archiv, 2020, vol. 476, p. 195-207
dc.rights.none.fl_str_mv cc-by (c)The authors, 2019
Attribution 4.0 International
info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
rights_invalid_str_mv cc-by (c)The authors, 2019
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Springer Nature
publisher.none.fl_str_mv Springer Nature
dc.source.none.fl_str_mv reponame:Repositori Obert UdL
instname:Universitat de Lleida (UdL)
instname_str Universitat de Lleida (UdL)
reponame_str Repositori Obert UdL
collection Repositori Obert UdL
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406417533796352
score 15,812429